United Drilling Tools

Buy 

Date: 24-12-2021

Qty: 26

Price: ₹382.55

Eps: ₹22.42

Sold

Date: 16-02-2023

Qty: 26

Price: ₹227.4

Eps: ₹7.21

The EPS has dropped by 67.8%

Holding period: 410 days

Loss: -₹4,033.9

Dividends: ₹55

Return %PA: -36%

Mangalam Organics Update

Reason for buying:

PE is reasonable and with more than 10 years PE median of 5.52.

Earnings have increased although unevenly in the last 5 years.

Operating margins have improved in the last 3 years.

Return on equity has improved in the last 3 years.

Debt is low at 20 cr and cash is 0.69 cr.

The threat of the company’s solvency is less; Altman Z-Score is 12.52

The market cap of the company is 648 cr.

 

Buy date: 05/14/2021

Buy Price: ₹704         Qty: 14         Buy EPS: ₹75.08        Buy PE: 9.37

27^th May 2021:

Q4 results: Current EPS is 99.21 and increased by 32.14% from my buy EPS.

Buy date: 07/13/2022

Price: ₹600.75    Qty: 16    EPS: ₹62.75    PE: 9.57

Sell date: 11/18/2022

Price: ₹534.75    Qty: 30    EPS: -₹13.84    PE is negative

It is making losses for the last 2 quarters so sold it. I lost ₹3,359.5 in this stock.

Disclaimer: The video is for educational purposes for my family and friends. I am not a financial advisor and do not consider it as buy or sell. Taking advice from a random guy on the internet is harmful to your portfolio. I do not do a deep analysis of stocks I buy them just as a hobby.

Jubilant Pharmova update

Reasons for buying:

Buy PE was reasonable at 10.64 and below 10 years PE median of 14.83.

Earnings have increased 6 times since 2013.

Return on equity is ok at 16.16%.

The market cap of the company is ₹10,006.84cr.

The debt of the company is ₹2,583.97cr with ₹671.32cr in cash. The debt is higher than my other investments but I think it's cheap, have to wait and see if I can make money on it.

Buy date: 28-Sep-2021

Qty: 16 Buy Price: ₹607 Buy EPS: ₹57.03 Buy PE: 10.64

Sell date: 27-Oct-2022

Qty:16 Price: ₹349.65 EPS: ₹10.24 PE: 34.14

The price of the stock is up about 3.19% from my buy price.

I have sold it at a loss of -₹4,037.6 after holding it for 394 days, I should not have bought it in the first place since it did not satisfy any of my rules. The earnings have dropped 82% from ₹57.03 to ₹10.24 and it is good that I have not added to stock when EPS dropped.

It is an integrated global pharmaceutical company with three business segments: Pharmaceuticals, Contract Research & Development services, and proprietary novel drugs.

Anjani Portland Cement

Reasons for buying:

Buy PE was reasonable at 11.54 and above 10 years PE median of 10.71.

Earnings have increased 5 times from 2015.

Return on equity is ok at 27.4%.

The market cap of the company is ₹1,025.33cr.

Zero debt company with ₹186.46cr in cash.

Buy date: 10-Oct-2021

Qty: 24 Buy Price: ₹406 Buy EPS: 35.17 Buy PE: 11.54

The price of the stock is down about -23.89% from my buy price. I will stop buying when EPS drops to 20.3.

Price dropped by 10% and added 10k worth of shares. The EPS is down by -15.38%.

Buy date: 15-Nov-2021

Qty: 27 Buy Price: ₹365.00 Buy EPS: 29.76 Buy PE: 12.26

Price dropped by 20% and added 10k worth of shares

Buy date: 23-Nov-2021

Qty: 33 Buy Price: ₹302.00 Buy EPS: 29.76 Buy PE: 10.14

The company's operating segments include cement and power plant. The company generates maximum revenue from the cement segment.

Buy date: 14-Feb-2022

Qty: 35 Buy Price: ₹284 Buy EPS: 25.48 Buy PE: 11.14

Buy date: 11-May-2022

Qty: 41 Buy Price: ₹241.95 Buy EPS: 25.48 Buy PE: 9.49

Sold the stock since EPS has fallen to 3.1

Sell date: 12-Aug-2022

Qty: 160 Buy Price: ₹211.55 Buy EPS: 3.1 Sell PE: 68.24